Financial giants have made a conspicuous bearish move on Thermo Fisher Scientific. Our analysis of options history for Thermo Fisher Scientific TMO revealed 14 unusual trades. Delving into the ...

We came across a bullish thesis on Thermo Fisher Scientific Inc. (TMO) on D Invests’ Substack. In this article, we will summarize the bulls’ thesis on TMO. Thermo Fisher Scientific Inc.

Recent discussions on X regarding Thermo Fisher Scientific (TMO) have centered around the company's reported plan to sell parts of its diagnostics division for approximately $4 billion. Many users ...

Thermo Fisher Scientific (NYSE:TMO) recently made headlines by entering a collaboration with Ethris GmbH to advance mRNA solutions and putting a $4 billion price tag on part of its diagnostics ...

Thermo Fisher Scientific (NYSE:TMO) recently made headlines by entering a collaboration with Ethris GmbH to advance mRNA solutions and putting a $4 billion price tag on part of its diagnostics unit ...

Thermo Fisher Scientific (NYSE: TMO) is looking to sell some of its lower-growth diagnostic assets for around $4B, the Financial Times reported, citing three people familiar with the matter.

Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported on Thursday, citing people ...

WALTHAM, Mass., June 02, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of the Thermo Scientific™ Orbitrap™ Astral™ Zoom ...

Thermo Fisher unveils Orbitrap Astral Zoom and Orbitrap Excedion Pro MS at ASMS 2025, advancing proteomics, drug development and disease research.

Thermo Fisher introduces next-gen mass spectrometry solutions at ASMS, designed to accelerate research in multiple scientific fields.

Thermo Fisher Scientific Inc., the world leader in serving science, today launched the spectral-enabled Invitrogen™ Attune™ Xenith™ Flow Cytometer, allowing immunology and immuno-oncology ...

Thermo Fisher Scientific stock may remain sluggish through November. What's behind the weakness and is TMO a buy now?